company
The Harvard Drug Group LLC
Jurisdiction: US
FDA Warning Letter timeline
V1 scope: FDA Warning Letters only. Additional public-record sources (SEC, CPSC, federal contracts) are on the V2 roadmap and are not surfaced here today.
- fda_recall · drug_recall2026-07-01The Harvard Drug Group LLC — Class II recall: Carton Label: MAJOR, Methylergonovine Maleate Tablets, USP, 0.2 mg, 20 TABLETS (…
- fda_recall · drug_recall2026-04-29The Harvard Drug Group LLC — Class II recall: Omega-3-Acid, Ethyl Esters, Capsules, USP, 1 gram, 50 capsules (5 x 10 unit dose…
- fda_recall · drug_recall2026-04-22The Harvard Drug Group LLC — Class II recall: Memantine Hydrochloride Extended-Release, Capsules, 7 mg, 100 Capsules (10 x 10…
Frequently asked questions
- How many FDA warning letters has The Harvard Drug Group LLC received?
- Argus HQ has not recorded an FDA warning letter for The Harvard Drug Group LLC in our current dataset.
- What FDA recalls has The Harvard Drug Group LLC issued?
- Argus HQ has recorded 3 FDA recalls tied to The Harvard Drug Group LLC.
- Is The Harvard Drug Group LLC FDA compliant?
- Argus HQ is not a compliance rating service. As of this page's last update, our dataset shows 0 warning letters, 3 recalls, and 0 approval records for The Harvard Drug Group LLC. Review the linked FDA source records directly before drawing a compliance conclusion.
Informational only. FDA Warning Letters are public records (17 USC §105). Summaries are AI-assisted and may contain errors; always verify against the original FDA letter before acting. Not legal, financial, or regulatory advice.

